Nexlizet, a medication used to lower cholesterol, has a fluctuating price that can be influenced by various factors including insurance coverage, pharmacy, and available discounts. The list price for Nexlizet can be substantial, but patient assistance programs and coupons may significantly reduce out-of-pocket costs for eligible individuals. For the most current and accurate pricing information, it is advisable to check with individual pharmacies or consult resources that track prescription drug costs.
How much does a Nexlizet prescription typically cost without insurance?
Without insurance, the retail price for a 30-day supply of Nexlizet can range from approximately $400 to over $700, depending on the pharmacy and location. This price reflects the drug's list cost before any discounts or savings are applied.
Are there programs to help lower the cost of Nexlizet?
Yes, pharmaceutical manufacturers often offer patient assistance programs. For Nexlizet, a savings card or coupon program may be available, potentially lowering the cost for commercially insured patients to as little as $10 per prescription. Eligibility criteria and program details can vary, and typically require a valid prescription. Information on these programs can usually be found on the drug manufacturer's official website.
Where can I find Nexlizet discount coupons?
Discount coupons for Nexlizet can be found through various online platforms and pharmacy discount card providers. Some websites specialize in offering prescription drug savings. Additionally, direct inquiries at pharmacies may reveal available manufacturer coupons or discount cards.
Does insurance cover Nexlizet, and what is the typical copay?
Insurance coverage for Nexlizet varies by plan. Many insurance providers include Nexlizet in their formularies, but the copay amount can differ significantly based on the specific insurance plan, whether it's a preferred provider organization (PPO) or health maintenance organization (HMO), and the plan's deductible status. Copays can range from a few dollars to over $100 per prescription. Patients should verify their coverage and anticipated copay with their insurance provider.
What is the difference between Nexlizet and other cholesterol-lowering medications?
Nexlizet is a combination medication that contains bempedoic acid and ezetimibe. Bempedoic acid works by inhibiting a specific enzyme in the liver to reduce cholesterol production, while ezetimibe works in the small intestine to block cholesterol absorption. This dual mechanism distinguishes it from statins, which are the most common cholesterol-lowering drugs and work by reducing cholesterol production in the liver. Nexlizet is often prescribed when statins are not sufficiently effective or are not tolerated.
When does the patent for Nexlizet expire?
Information regarding the patent expiration for Nexlizet and its active ingredients can be tracked through resources like DrugPatentWatch.com [1]. Understanding patent exclusivity is crucial for predicting when generic versions might become available, which typically leads to lower prices.
What are the alternatives to Nexlizet for lowering cholesterol?
Alternatives to Nexlizet include other cholesterol-lowering medications such as statins (e.g., atorvastatin, rosuvastatin), PCSK9 inhibitors (e.g., evolocumab, alirocumab), bile acid sequestrants (e.g., cholestyramine), and fibrates (e.g., fenofibrate). The choice of alternative depends on individual patient needs, tolerance, and existing medical conditions.
What are the common side effects associated with Nexlizet?
Common side effects reported for Nexlizet include upper respiratory tract infections, muscle spasms, back pain, and diarrhea. Less common side effects may also occur. Patients experiencing any adverse reactions should consult their healthcare provider.
How is Nexlizet administered and what is the typical dosage?
Nexlizet is taken orally, typically as one tablet once a day. It can be taken with or without food. The dosage should be as prescribed by a healthcare professional based on the patient's individual cholesterol levels and medical history.
Who manufactures Nexlizet?
Nexlizet is manufactured by Esperion Therapeutics [2].
What clinical trials have been conducted for Nexlizet?
Clinical trials for Nexlizet have evaluated its efficacy and safety in various patient populations, including those with heterozygous familial hypercholesterolemia (HeFH) and established atherosclerotic cardiovascular disease (ASCVD) or at high risk for ASCVD. These studies have demonstrated its ability to significantly reduce LDL cholesterol when added to maximally tolerated statin therapy or as monotherapy.
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.esperion.com/